Introduction:Stress urinary incontinence (SUI), though is more prevalent than many chronic diseases, has remained largely underreported and underdiagnosed condition. We aimed to find the improvement in the quality of life (QoL) of women with SUI after individual interventions, namely mid-urethral sling (MUS), pelvic floor muscle training (PFMT), and no treatment/control group, as primary treatment modalities.Materials and Methods:This was a prospective interventional case–control study conducted at a university teaching hospital, over a period of 2 years. Parous women with at least one vaginal delivery, attending the gynecology outpatient department, were encouraged to fill the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form. Those with SUI were divided into three arms (MUS, PFMT, and no treatment/control group), according to the informed decision for choice of management. Baseline QoL was documented for all with King's Health Questionnaire. QoL was again recorded after 3 months of the start of treatment and was compared with the baseline.Results:In our study cohort, the prevalence of SUI was 15.2%, with a consultation rate of only 30.7%. MUS surgery improves QoL significantly in women with SUI, followed by PFMT. We found 100% symptomatic relief, high rate of improvement in QoL with minimal easy to manage complications, in the surgical intervention arm. PFMT, though has a positive impact on QoL, requires continuous motivation, as 22% discontinued. Without treatment, QoL in SUI patients remained more or less the same.Conclusion:The help-seeking behavior (consultation rate) for SUI is poor. MUS (surgical arm) had 100% symptom relief in 3-month follow-up. MUS showed the best results in terms of QoL improvement, followed by PFMT in SUI in our study. It is important not only to educate women about the problem but also to encourage them to seek treatment and indicate that it is a treatable condition.
Objectives: To evaluate the obstetrics outcome in terms of maternal mortality in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected pregnant women in both the waves of coronavirus disease 2019 (COVID-19) pandemic. Design, settings, and participants: This is a prospective cohort study of obstetrics outcomes in SARS-CoV-2 infected pregnant women in both the waves of COVID-19 pandemic from 1 April 2020 to 30 May 2021 at Sri Aurobindo Institute of Medical Sciences with wide spread access to SARS-CoV-2 testing in outpatients, emergency department, and inpatient settings. Result: The primary outcome composed of maternal mortality in SARS-CoV-2 infected females during both waves of COVID-19 pandemic. Study shows that the second wave was more intense and fatal as compared to the first wave of COVID-19 pandemic in India with higher maternal mortality rate in the second wave than the first wave. Study also showed that an overall higher mortality with cesarean section was noted. Thus, our study concluded that the cesarean section is not the preferred mode of delivery in COVID-19 females suffering from respiratory distress. Conclusion: Our study concluded that cesarean section is not the preferred mode of delivery in COVID-19 with females suffering from respiratory distress. The SARS-CoV-2 infection during pregnancy was associated with adverse maternal outcomes post-delivery.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.